Thrombolysis related symptomatic intracranial hemorrhage in estimated versus measured body weight.
T Truc My NguyenStephanie Iw van de StadtAdrien E GrootMarieke Jh WermerHeleen M den HertogHanneke M DrosteErik W van ZwetSander M van SchaikJonathan M CoutinhoNyika D KruytPublished in: International journal of stroke : official journal of the International Stroke Society (2019)
We did not find evidence that weight modality (estimation of body weight versus measurement of body weight) to determine recombinant tissue plasminogen activator dose in intravenous thrombolysis eligible patients is associated with symptomatic intracranial hemorrhage or clinical outcome. We did find that estimation of body weight leads to longer door-to-needle times compared to measurement of body weight using an inbuilt weighing bed and to shorter door-to-needle times compared to measurement of body weight using a patient lift scale.